1.Which role best describes your primary responsibility?

Clinical Development / Clinical Operations

Translational Medicine

Data Science / Advanced Analytics

Biometrics / Statistics

Medical Affairs

R&D Leadership / Portfolio Strategy

Other (please specify)

2.Who primarily owns clinical trial design decisions in your organization?

Clinical Operations

Translational / Precision Medicine

Biostatistics

External CROs

Cross-functional committee

Not clearly defined

3.How long does it typically take to design and finalize a clinical trial protocol (pre-FPI)?

< 2 weeks

2–4 weeks

1–2 months

3–6 months

6 months

4.How long does patient selection and feasibility analysis typically take today?

< 1 week

1–2 weeks

1 month

2–3 months

> 3 months

5.What are the biggest bottlenecks in trial design and patient selection today?

Fragmented or poor-quality data

Manual feasibility analysis

Limited access to real-world patient data

Rework due to protocol amendments

Slow CRO handoffs

Lack of predictive insights

Internal resourcing constraints

Cost

All of the Above

6.Which areas contribute most to cost overruns or inefficiency?

Protocol amendments

Site selection errors

Patient recruitment delays

Under-enrollment / screen failures

Data reconciliation and reanalysis

CRO change orders

7.If AI-powered software could reduce trial design and patient selection from months/weeks to hours/minutes, how valuable would that be?

Not valuable

Somewhat valuable

Valuable

Very valuable

Mission-critical

8.How comfortable would you be using AI-driven insights to inform trial design and patient selection decisions?

Not comfortable

Comfortable only as a secondary input

Comfortable with human review

Comfortable for most decisions

Fully comfortable if validated and auditable

9.What is the value to your organization for an AI-powered trial design and patient selection platform that can improve efficiencies by 75%?

< $100k annually

> $100k but < $200k annually

> $200k but < $500k annually

> $500k but < $1M annually

>$1M

Other (please specify)

10.At what annual investment level would this type of capability require senior leadership approval?

< $50K

$50K–$150K

$150K–$300K

$300K–$500K

> $500K